T 0977/93 (Canine coronavirus vaccine) du 30.03.1999
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:1999:T097793.19990330
- Date de la décision
- 30 mars 1999
- Numéro de l'affaire
- T 0977/93
- Requête en révision de
- -
- Numéro de la demande
- 84902632.3
- Classe de la CIB
- A61K 39/12
- Langue de la procédure
- Anglais
- Distribution
- Publiées au Journal officiel de l'OEB (A)
- Téléchargement
- Décision en anglais
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- VACCIN CONTRE LE CORONAVIRUS CANIN
- Nom du demandeur
- American Home Products Corporation
- Nom de l'opposant
- Rhoôe Mérieux
- Chambre
- 3.3.04
- Sommaire
A product made available to the public is not reproducible within the meaning of decision G 0001/92 (point 4.1) and thus does not belong to the state of the art if the skilled person is not in a position to establish identity of the reproduced product with the commercially available product because the intrinsic and extrinsic features of the product are not accessible and there is a high probability of variation upon reproduction. (See points 11.1 to 11.3 and 12 of the "Reasons")
- Dispositions juridiques pertinentes
- European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973
- Mots-clés
- Availability of the intrinsic and extrinsic features of a vaccine (no)
Inventive step (yes) - Exergue
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the main request as filed in the oral proceedings.